Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M777Revenue (TTM) $M90.1Net Margin (%)-41.6Altman Z-Score2.9
Enterprise Value $M690EPS (TTM) $-0.4Operating Margin %-39.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score18.3Pre-tax Margin (%)-41.6Higher ROA y-yY
Price/Book7.110-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsN
Price/Sales7.65-y EBITDA Growth Rate %-62.2Current Ratio4.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-29.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-54.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M91.9ROIC % (ttm)-1,373.4Gross Margin Increase y-yY

Gurus Latest Trades with PACB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PACBRonald Muhlenkamp 2015-12-31 Sold Out -0.01%$6.13 - $13.45
($9.11)
$ 8.46-7%Sold Out0
PACBRonald Muhlenkamp 2015-09-30 Buy 0.01%$3.66 - $5.8
($4.89)
$ 8.4673%New holding11,125
PACBFirst Eagle Investment 2012-09-30 Sold Out -0.0013%$1.7 - $2.32
($1.96)
$ 8.46332%Sold Out0
PACBFirst Eagle Investment 2012-03-31 Buy $2.94 - $5.04
($3.71)
$ 8.46128%New holding150,000
PACBGeorge Soros 2011-09-30 Sold Out -0.0018%$3.55 - $12.24
($7.91)
$ 8.467%Sold Out0
PACBGeorge Soros 2011-06-30 Buy $10.44 - $13.53
($11.8)
$ 8.46-28%New holding10,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PACB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PACB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Phillips James MichaelSVP, Research & Development 2016-07-29Sell20,000$8.450.12view
Phillips James MichaelSVP, Research & Development 2016-04-25Sell20,000$10.29-17.78view
Phillips James MichaelSVP, Research & Development 2015-08-07Sell16,689$4.6183.51view
Phillips James MichaelSVP, Research & Development 2015-03-02Buy1,877$4.9172.3view
CORCORAN KEVIN PSVP, Market Development 2015-03-02Buy2,816$4.9172.3view
Dow Brian BVP and PAO 2015-03-02Buy2,503$4.9172.3view
Ericson William W.Director 2014-08-19Buy39,299$5.1464.59view
Ericson William W.Director 2014-08-18Buy135,155$5.0966.21view
Ericson William W.Director 2014-08-14Buy77,822$569.2view
Ericson William W.Director 2014-08-13Buy29,435$4.9371.6view

Quarterly/Annual Reports about PACB:

News about PACB:

Articles On GuruFocus.com
Meridian Funds Comments on Pacific Biosciences of California Inc. Mar 08 2016 
Weekly CEO Buys Highlight: CLR, CLMS, OPK, PACB, GAIN Dec 16 2013 
Weekly CEO Buys Highlight: OPK, PACB, CUBI, ARCP, RLYP Nov 25 2013 
Weekly CEO Buys Highlight: PHII, TUES, PACB, IPHI, WMC Dec 09 2012 
Weekly CEO Buys Highlight: PACB, AKS, EPIQ, GGS, TPGI Dec 02 2012 
Weekly CEO Buys Highlight: FFIN, STEC, MPO, PACB, TPGI Nov 25 2012 
Weekly CEO Buys Highlight: SUNS, PACB, GM, NPO, DGX Aug 11 2012 

More From Other Websites
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Financials Aug 12 2016
ETF’s with exposure to Pacific Biosciences of California, Inc. : August 9, 2016 Aug 09 2016
Pacific Biosciences of California, Inc. breached its 50 day moving average in a Bullish Manner :... Aug 08 2016
Edited Transcript of PACB earnings conference call or presentation 4-Aug-16 8:30pm GMT Aug 05 2016
Pacific Biosciences (PACB) Q2 Impressive, View Encourages Aug 05 2016
Pacific Biosciences reports 2Q loss Aug 04 2016
Pacific Biosciences reports 2Q loss Aug 04 2016
Pacific Biosciences Releases New Software and Chemistry for Sequel System Aug 04 2016
Pacific Biosciences of California, Inc. Announces Second Quarter 2016 Financial Results Aug 04 2016
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 10-Q, Quarterly Report Aug 04 2016
Pacific Biosciences Releases New Software and Chemistry for Sequel System Aug 04 2016
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Results of Operations and Financial... Aug 04 2016
Pacific Biosciences of California, Inc. Announces Second Quarter 2016 Financial Results Aug 04 2016
Q2 2016 Pacific Biosciences of California Inc Earnings Release - After Market Close Aug 04 2016
Pacific Biosciences (PACB) Q2 Earnings: What's in Store? Aug 01 2016
HistoGenetics Wins Multi-Year Contract for HLA Typing Using PacBio Sequencing Aug 01 2016
HistoGenetics Wins Multi-Year Contract for HLA Typing Using PacBio Sequencing Aug 01 2016
Pacific Biosciences of California, Inc. breached its 50 day moving average in a Bullish Manner :... Jul 29 2016
ETF’s with exposure to Pacific Biosciences of California, Inc. : July 18, 2016 Jul 18 2016
Pacific Biosciences of California, Inc. Second Quarter 2016 Financial Results Call Jul 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)